Table 4.
Histopathologic characteristic | Patients with symptoms related to SARS-CoV-2 infection (n=16) | Patients without symptoms related to SARS-CoV-2 infection (n=34) | P value |
---|---|---|---|
Placental weight | |||
<10th percentile | 1 (6.2) | 6 (17.6) | .32 |
10th–90th percentile | 13 (81.2) | 27 (79.4) | |
>90th percentile | 2 (12.5) | 1 (2.9) | |
Maternal vascular malperfusion | |||
Distal villous hypoplasia | 0 | 2 (5.9) | 1 |
Excessive infarction | 3 (18.8) | 1 (2.9) | .09 |
Old hemorrhage in membranes | 1 (6.2) | 0 | .32 |
Fetal vascular malperfusion | 1 (6.2) | 3 (8.8) | 1 |
Increased perivillous fibrin | 2 (12.5) | 4 (11.8) | 1 |
Intervillous thrombus | 6 (37.5) | 7 (20.6) | .3 |
Delayed villous maturation | 2 (12.5) | 8 (23.5) | .47 |
Villitis | 0 | 2 (5.9) | 1 |
Chorionitis | 2 (12.5) | 9 (26.5) | .47 |
Amnionitis | 2 (12.5) | 7 (20.6) | .7 |
Umbilical vasculitis | 2 (12.5) | 5 (14.7) | 1 |
Retroplacental thrombus | 2 (12.5) | 0 | .1 |
Chorangiosis | 1 (6.2) | 2 (5.9) | 1 |
Meconium staining | 4 (25) | 5 (14.7) | .44 |
Data are presented as number (percentage).
SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.
Gulersen et al. Placental histopathologic changes after maternal SARS-CoV-2 infection. AJOG MFM 2020.